Effect of the nicotinic α4β2-receptor partial agonist varenicline on non-invasive brain stimulation-induced neuroplasticity in the human motor cortex

Cerebral Cortex

Volumn 25, Issue 9, 2015, Pages 3249-3259

  Batsikadze, Giorgi ^a   Paulus, Walter ^a   Grundey, Jessica ^a   Kuo, Min Fang ^a   Nitsche, Michael A ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Human motor cortex; Neuroplasticity; Nicotine; Paired associative stimulation; Transcranial direct current stimulation

Indexed keywords

PLACEBO; VARENICLINE; NICOTINIC AGENT;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; COGNITION; DIZZINESS; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROMYOGRAPHY; FEMALE; HUMAN; LOW DRUG DOSE; MALE; MOTOR CORTEX; MOTOR EVOKED POTENTIAL; NERVE CELL PLASTICITY; NORMAL HUMAN; PAIRED ASSOCIATIVE STIMULATION; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; TRANSCRANIAL DIRECT CURRENT STIMULATION; ANALYSIS OF VARIANCE; BIOPHYSICS; DOSE RESPONSE; DRUG EFFECTS; PHYSIOLOGY; TRANSCRANIAL MAGNETIC STIMULATION; YOUNG ADULT;

ADULT; ANALYSIS OF VARIANCE; BIOPHYSICS; DOSE-RESPONSE RELATIONSHIP, DRUG; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MALE; MOTOR CORTEX; NEURONAL PLASTICITY; NICOTINIC AGONISTS; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; VARENICLINE; YOUNG ADULT;

EID: 84973426149     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhu126     Document Type: Article

References (132)

1. Andresen JH, Loberg EM, Wright M, Goverud IL, Stray-Pedersen B, Saugstad OD. 2009. Nicotine affects the expression of brain-derived neurotrophic factor mRNA and protein in the hippocampus of hypoxic newborn piglets. J Perinatal Med. 37:553-560.
2. Antal A, Chaieb L, Moliadze V, Monte-Silva K, Poreisz C, Thirugnanasambandam N, Nitsche MA, Shoukier M, Ludwig H, Paulus W. 2010. Brain-derived neurotrophic factor (BDNF) gene polymorphisms shape cortical plasticity in humans. Brain Stimul. 3:230-237.
3. Antal A, Nitsche MA, Kruse W, Kincses TZ, Hoffmann KP, Paulus W. 2004. Direct current stimulation over V5 enhances visuomotor coordination by improving motion perception in humans. J Cogn Neurosci. 16:521-527.
4. Anthenelli RM, Morris C, Ramey TS, Dubrava SJ, Tsilkos K, Russ C, Yunis C. 2013. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Ann Int Med. 159:390-400.
5. Avalos M, Parker MJ, Maddox FN, Carroll FI, Luetje CW. 2002. Effects of pyridine ring substitutions on affinity, efficacy, and subtype selectivity of neuronal nicotinic receptor agonist epibatidine. J Pharmacol Exp Ther. 302:1246-1252.
6. Awtry TL, Werling LL. 2003. Acute and chronic effects of nicotine on serotonin uptake in prefrontal cortex and hippocampus of rats. Synapse. 50:206-211.
7. Batsikadze G, Paulus W, Kuo MF, Nitsche MA. 2013. Effect of serotonin on paired associative stimulation-induced plasticity in the human motor cortex. Neuropsychopharmacology. 38:2260-2267.
8. Bear MF 1999. Homosynaptic long-term depression: a mechanism for memory? Proc Natl Acad Sci USA. 96:9457-9458.
9. Bhang SY, Choi SW, Ahn JH. 2010. Changes in plasma brain-derived neurotrophic factor levels in smokers after smoking cessation. Neurosci Lett. 468:7-11.
10. Buisson B, Bertrand D. 2001. Chronic exposure to nicotine upregulates the human (alpha)4((beta)2 nicotinic acetylcholine receptor function. J Neurosci. 21:1819-1829.
11. Burnashev N. 1998. Calcium permeability of ligand-gated channels. Cell Calcium. 24:325-332.
12. Caporale N, Dan Y. 2008. Spike timing-dependent plasticity: a Hebbian learning rule. Ann Rev Neurosci. 31:25-46.
13. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johnson EC. 1997. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes. J Pharmacol Exp Ther. 280:346-356.
14. Chavez-Noriega LE, Gillespie A, Stauderman KA, Crona JH, Claeps BO, Elliott KJ, Reid RT, Rao TS, Velicelebi G, Harpold MM et al. 2000. Characterization of the recombinant human neuronal nicotinic acetylcholine receptors alpha3beta2 and alpha4beta2 stably expressed in HEK293 cells. Neuropharmacology. 39:2543-2560.
15. Cheeran B, Talelli P, Mori F, Koch G, Suppa A, Edwards M, Houlden H, Bhatia K, Greenwood R, Rothwell JC. 2008. A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol. 586:5717-5725.
16. Cirillo J, Rogasch NC, Semmler JG. 2010. Hemispheric differences in use-dependent corticomotor plasticity in young and old adults. Exp Brain Res. 205:57-68.
17. Cirillo J, Todd G, Semmler JG. 2011. Corticomotor excitability and plasticity following complex visuomotor training in young and old adults. Eur J Neurosci. 34:1847-1856.
18. Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, Sands SB, Davis TI, Lebel LA, Fox CB et al. 2005. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem. 48:3474-3477.
19. Cole DM, Beckmann CF, Long CJ, Matthews PM, Durcan MJ, Beaver JD. 2010. Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics. Neuroimage. 52:590-599.
20. Collingridge GL, Peineau S, Howland JG, Wang YT. 2010. Long-term depression in the CNS. Nat Rev Neurosci. 11:459-473.
21. Crunelle CL, de Wit TC, de Bruin K, Ramakers RM, van der Have F, Beekman FJ, van den Brink W, Booij J. 2012. Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats. Nucl Med Biol. 39:640-644.
22. Crunelle CL, Miller ML, de Bruin K, van den Brink W, Booij J. 2009. Varenicline increases striatal dopamine D(2/3) receptor binding in rats. Addict Biol. 14:500-502.
23. Crunelle CL, Schulz S, de Bruin K, Miller ML, van den Brink W, Booij J. 2011. Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats. Eur Neuropsychopharmacol. 21:205-210.
24. Dajas-Bailador F, Wonnacott S. 2004. Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci. 25:317-324.
25. Di Lazzaro V, Oliviero A, Profice P, Pennisi MA, Di Giovanni S, Zito G, Tonali P, Rothwell JC. 2000. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res. 135:455-461.
26. Di Lazzaro V, Oliviero A, Saturno E, Dileone M, Pilato F, Nardone R, Ranieri F, Musumeci G, Fiorilla T, Tonali P. 2005. Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol. 564:661-668.
27. Di Lazzaro V, Oliviero A, Tonali PA, Marra C, Daniele A, Profice P, Saturno E, Pilato F, Masullo C, Rothwell JC. 2002. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology. 59:392-397.
28. Doll R, Peto R, Boreham J, Sutherland I. 2005. Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer. 92:426-429.
29. DuBois DW, Damborsky JC, Fincher AS, Frye GD, Winzer-Serhan UH. 2013. Varenicline and nicotine enhance GABAergic synaptic transmission in rat CA1 hippocampal and medial septum/diagonal band neurons. Life Sci. 92:337-344.
30. Faessel HM, Obach RS, Rollema H, Ravva P, Williams KE, Burstein AH. 2010. A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation. Clin Pharmacokinet. 49:799-816.
31. Faessel HM, Smith BJ, Gibbs MA, Gobey JS, Clark DJ, Burstein AH. 2006. Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers. J Clin Pharmacol. 46:991-998.
32. 2+ permeability of nicotinic acetylcholine receptors in rat hippocampal CA1 interneurones. J Physiol. 566:759-768.
33. 2+ signalling due to activation of alpha 7-containing nicotinic acetylcholine receptors in rat hippocampal neurons. J Physiol. 582:597-611.
34. Fenster CP, Beckman ML, Parker JC, Sheffield EB, Whitworth TL, Quick MW, Lester RA. 1999. Regulation of alpha4beta2 nicotinic receptor desensitization by calcium and protein kinase C. Mol Pharmacol. 55:432-443.
35. Fenster CP, Rains MF, Noerager B, Quick MW, Lester RA. 1997. Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J Neurosci. 17:5747-5759.
36. Freitas C, Perez J, Knobel M, Tormos JM, Oberman L, Eldaief M, Bashir S, Vernet M, Pena-Gomez C, Pascual-Leone A. 2011. Changes in cortical plasticity across the lifespan. Front Aging Neurosci. 3:5.
37. Fritsch B, Reis J, Martinowich K, Schambra HM, Ji Y, Cohen LG, Lu B. 2010. Direct current stimulation promotes BDNF-dependent synaptic plasticity: potential implications for motor learning. Neuron. 66:198-204.
38. Froeliger B, Gilbert DG, McClernon FJ. 2009. Effects of nicotine on novelty detection and memory recognition performance: doubleblind, placebo-controlled studies of smokers and nonsmokers. Psychopharmacology (Berl). 205:625-633.
39. Fujii S, Jia Y, Yang A, Sumikawa K. 2000. Nicotine reverses GABAergic inhibition of long-term potentiation induction in the hippocampal CA1 region. Brain Res. 863:259-265.
40. Fujii S, Sumikawa K. 2001a. Acute and chronic nicotine exposure reverse age-related declines in the induction of long-term potentiation in the rat hippocampus. Brain Res. 894:347-353.
41. Fujii S, Sumikawa K. 2001b. Nicotine accelerates reversal of long-term potentiation and enhances long-term depression in the rat hippocampal CA1 region. Brain Res. 894:340-346.
42. Ge S, Dani JA. 2005. Nicotinic acetylcholine receptors at glutamate synapses facilitate long-term depression or potentiation. J Neurosci. 25:6084-6091.
43. Griffiths S, Scott H, Glover C, Bienemann A, Ghorbel MT, Uney J, Brown MW, Warburton EC, Bashir ZI. 2008. Expression of long-term depression underlies visual recognition memory. Neuron. 58:186-194.
44. Griguoli M, Cellot G, Cherubini E. 2013. In hippocampal oriens interneurons anti-Hebbian long-term potentiation requires cholinergic signaling via alpha7 nicotinic acetylcholine receptors. J Neurosci. 33:1044-1049.
45. Grundey J, Thirugnanasambandam N, Kaminsky K, Drees A, Skwirba AC, Lang N, Paulus W, Nitsche MA. 2012a. Neuroplasticity in cigarette smokers is altered under withdrawal and partially restituted by nicotine exposition. J Neurosci. 32:4156-4162.
46. Grundey J, Thirugnanasambandam N, Kaminsky K, Drees A, Skwirba AC, Lang N, Paulus W, Nitsche MA. 2012b. Rapid effect of nicotine intake on neuroplasticity in non-smoking humans. Front Pharmacol. 3:186.
47. Hahn B, Shoaib M, Stolerman IP. 2002. Nicotine-induced enhancement of attention in the five-choice serial reaction time task: the influence of task demands. Psychopharmacology (Berl). 162:129-137.
48. Hahn B, Stolerman IP. 2002. Nicotine-induced attentional enhancement in rats: effects of chronic exposure to nicotine. Neuropsychopharmacology. 27:712-722.
49. Heishman SJ, Kleykamp BA, Singleton EG. 2010. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl). 210:453-469.
50. Hong LE, Thaker GK, McMahon RP, Summerfelt A, Rachbeisel J, Fuller RL, Wonodi I, Buchanan RW, Myers C, Heishman SJ et al. 2011. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 68:1195-1206.
51. Hsu YN, Amin J, Weiss DS, Wecker L. 1996. Sustained nicotine exposure differentially affects alpha 3 beta 2 and alpha 4 beta 2 neuronal nicotinic receptors expressed in Xenopus oocytes. J Neurochem. 66:667-675.
52. Inghilleri M, Berardelli A, Marchetti P, Manfredi M. 1996. Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp Brain Res. 109:467-472.
53. Jacobsen LK, Krystal JH, Mencl WE, Westerveld M, Frost SJ, Pugh KR. 2005. Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol Psychiatry. 57:56-66.
54. Jensen AA, Frolund B, Liljefors T, Krogsgaard-Larsen P. 2005. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J Med Chem. 48:4705-4745.
55. 2+ entry through non-alpha7 nicotinic acetylcholine receptors. Eur J Neurosci. 31:463-476.
56. Jones GM, Sahakian BJ, Levy R, Warburton DM, Gray JA. 1992. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology (Berl). 108:485-494.
57. Jubelt LE, Barr RS, Goff DC, Logvinenko T, Weiss AP, Evins AE. 2008. Effects of transdermal nicotine on episodic memory in nonsmokers with and without schizophrenia. Psychopharmacology (Berl). 199:89-98.
58. Karadsheh MS, Shah MS, Tang X, Macdonald RL, Stitzel JA. 2004. Functional characterization of mouse alpha4beta2 nicotinic acetylcholine receptors stably expressed in HEK293T cells. J Neurochem. 91:1138-1150.
59. Kem WR 2000. The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21). Behav Brain Res. 113:169-181.
60. Kemp A, Manahan-Vaughan D. 2008. The hippocampal CA1 region and dentate gyrus differentiate between environmental and spatial feature encoding through long-term depression. Cereb Cortex. 18:968-977.
61. Kemp A, Manahan-Vaughan D. 2007. Hippocampal long-term depression: master or minion in declarative memory processes? Trends Neurosci. 30:111-118.
62. Kenny PJ, File SE, Rattray M. 2000. Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res Mol Brain Res. 85:234-238.
63. 2+ regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons. J Neurosci. 23:9024-9031.
64. Kumari V, Gray JA, ffytche DH, Mitterschiffthaler MT, Das M, Zachariah E, Vythelingum GN, Williams SC, Simmons A, Sharma T. 2003. Cognitive effects of nicotine in humans: an fMRI study. Neuroimage. 19:1002-1013.
65. Kuo MF, Grosch J, Fregni F, Paulus W, Nitsche MA. 2007. Focusing effect of acetylcholine on neuroplasticity in the human motor cortex. J Neurosci. 27:14442-14447.
66. Kuo MF, Paulus W, Nitsche MA. 2008. Boosting focally-induced brain plasticity by dopamine. Cereb Cortex. 18:648-651.
67. Lang N, Hasan A, Sueske E, Paulus W, Nitsche MA. 2008. Cortical hypoexcitability in chronic smokers? A transcranial magnetic stimulation study. Neuropsychopharmacology. 33:2517-2523.
68. Levin ED, McClernon FJ, Rezvani AH. 2006. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl). 184:523-539.
69. 2+ levels affect plasticity differently: the LTP zone, the LTD zone and no man's land. J Physiol. 532:285.
70. Liu ME, Tsai SJ, Jeang SY, Peng SL, Wu SL, Chen MC, Tsai YL, Yang ST. 2011. Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia. Psychiatry Res. 190:79-84.
71. Loughead J, Ray R, Wileyto EP, Ruparel K, Sanborn P, Siegel S, Gur RC, Lerman C. 2010. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol Psychiatry. 67:715-721.
72. Lummis SC, Thompson AJ, Bencherif M, Lester HA. 2011. Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor. J Pharmacol Exp Ther. 339:125-131.
73. Martinowich K, Lu B. 2008. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology. 33:73-83.
74. Matsuyama S, Matsumoto A. 2003. Epibatidine induces long-term potentiation (LTP) via activation of alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: both alpha7 and alpha4beta2 nAChRs essential to nicotinic LTP. J Pharmacol Sci. 93:180-187.
75. Matsuyama S, Matsumoto A, Enomoto T, Nishizaki T. 2000. Activation of nicotinic acetylcholine receptors induces long-term potentiation in vivo in the intact mouse dentate gyrus. Eur J Neurosci. 12:3741-3747.
76. Mihalak KB, Carroll FI, Luetje CW. 2006. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol. 70:801-805.
77. Misonou H, Mohapatra DP, Park EW, Leung V, Zhen D, Misonou K, Anderson AE, Trimmer JS. 2004. Regulation of ion channel localization and phosphorylation by neuronal activity. Nat Neurosci. 7:711-718.
78. Mocking RJ, Patrick Pflanz C, Pringle A, Parsons E, McTavish SF, Cowen PJ, Harmer CJ. 2012. Effects of short-term varenicline administration on emotional and cognitive processing in healthy, nonsmoking adults: a randomized, double-blind, study. Neuropsychopharmacology. 38:476-484.
79. Monte-Silva K, Kuo MF, Thirugnanasambandam N, Liebetanz D, Paulus W, Nitsche MA. 2009. Dose-dependent inverted U-shaped effect of dopamine (D2-like) receptor activation on focal and nonfocal plasticity in humans. J Neurosci. 29:6124-6131.
80. Monte-Silva K, Liebetanz D, Grundey J, Paulus W, Nitsche MA. 2010. Dosage-dependent non-linear effect of L-DOPA on human motor cortex plasticity. J Physiol. 588:3415-3424.
81. Mugnaini M, Tessari M, Tarter G, Merlo Pich E, Chiamulera C, Bunnemann B. 2002. Upregulation of [3H]methyllycaconitine binding sites following continuous infusion of nicotine, without changes of alpha7 or alpha6 subunit mRNA: an autoradiography and in situ hybridization study in rat brain. Eur J Neurosci. 16:1633-1646.
82. Muller-Dahlhaus JF, Orekhov Y, Liu Y, Ziemann U. 2008. Interindividual variability and age-dependency of motor cortical plasticity induced by paired associative stimulation. Exp Brain Res. 187:467-475.
83. ∗ nicotinic ACh receptors. Eur J Neurosci. 25:2666-2681.
84. Nibuya M, Morinobu S, Duman RS. 1995. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 15:7539-7547.
85. Nitsche MA, Cohen LG, Wassermann EM, Priori A, Lang N, Antal A, Paulus W, Hummel F, Boggio PS, Fregni F et al. 2008. Transcranial direct current stimulation: state of the art 2008. Brain Stimul. 1:206-223.
86. Nitsche MA, Doemkes S, Karakose T, Antal A, Liebetanz D, Lang N, Tergau F, Paulus W. 2007. Shaping the effects of transcranial direct current stimulation of the human motor cortex. J Neurophysiol. 97:3109-3117.
87. Nitsche MA, Fricke K, Henschke U, Schlitterlau A, Liebetanz D, Lang N, Henning S, Tergau F, Paulus W. 2003. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J Physiol. 553:293-301.
88. Nitsche MA, Kuo MF, Karrasch R, Wachter B, Liebetanz D, Paulus W. 2009. Serotonin affects transcranial direct current-induced neuroplasticity in humans. Biol Psychiatry. 66:503-508.
89. Nitsche MA, Liebetanz D, Schlitterlau A, Henschke U, Fricke K, Frommann K, Lang N, Henning S, Paulus W, Tergau F. 2004. GABAergic modulation of DC stimulation-induced motor cortex excitability shifts in humans. Eur J Neurosci. 19:2720-2726.
90. Nitsche MA, Nitsche MS, Klein CC, Tergau F, Rothwell JC, Paulus W. 2003. Level of action of cathodal DC polarisation induced inhibition of the human motor cortex. Clin Neurophysiol. 114:600-604.
91. Nitsche MA, Paulus W. 2000. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol. 527:633-639.
92. Nitsche MA, Paulus W. 2001. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology. 57:1899-1901.
93. Nitsche MA, Roth A, Kuo MF, Fischer AK, Liebetanz D, Lang N, Tergau F, Paulus W. 2007. Timing-dependent modulation of associative plasticity by general network excitability in the human motor cortex. J Neurosci. 27:3807-3812.
94. Normann C, Schmitz D, Furmaier A, Doing C, Bach M. 2007. Long-term plasticity of visually evoked potentials in humans is altered in major depression. Biol Psychiatry. 62:373-380.
95. Obach RS, Reed-Hagen AE, Krueger SS, Obach BJ, O'Connell TN, Zandi KS, Miller S, Coe JW. 2006. Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro. Drug Metab Dispos. 34:121-130.
96. Oldfield RC 1971. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 9:97-113.
97. Parker SL, Fu Y, McAllen K, Luo J, McIntosh JM, Lindstrom JM, Sharp BM. 2004. Up-regulation of brain nicotinic acetylcholine receptors in the rat during long-term self-administration of nicotine: disproportionate increase of the alpha6 subunit. Mol Pharmacol. 65:611-622.
98. Patterson F, Jepson C, Loughead J, Perkins K, Strasser AA, Siegel S, Frey J, Gur R, Lerman C. 2009. Working memory deficits predict shortterm smoking resumption following brief abstinence. Drug Alcohol Depend. 106:61-64.
99. Paulus W, Classen J, Cohen LG, Large CH, Di Lazzaro V, Nitsche M, Pascual-Leone A, Rosenow F, Rothwell JC, Ziemann U. 2008. State of the art: pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation. Brain Stimul. 1:151-163.
100. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr. 1992. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet. 339:1268-1278.
101. Pietila K, Ahtee L. 2000. Chronic nicotine administration in the drinking water affects the striatal dopamine in mice. Pharmacol Biochem Behav. 66:95-103.
102. Prestori F, Bonardi C, Mapelli L, Lombardo P, Goselink R, De Stefano ME, Gandolfi D, Mapelli J, Bertrand D, Schonewille M et al. 2013. Gating of long-term potentiation by nicotinic acetylcholine receptors at the cerebellum input stage. PLoS One. 8:e64828.
103. Provost SC, Woodward R. 1991. Effects of nicotine gum on repeated administration of the Stroop test. Psychopharmacology (Berl). 104:536-540.
104. Purpura DP, McMurtry JG. 1965. Intracellular activities and evoked potential changes during polarization of motor cortex. J Neurophysiol. 28:166-185.
105. Rahman S, Zhang J, Engleman EA, Corrigall WA. 2004. Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study. Neuroscience. 129:415-424.
106. Rezvani AH, Levin ED. 2001. Cognitive effects of nicotine. Biol Psychiatry. 49:258-267.
107. Rogasch NC, Dartnall TJ, Cirillo J, Nordstrom MA, Semmler JG. 2009. Corticomotor plasticity and learning of a ballistic thumb training task are diminished in older adults. J Appl Physiol. 107:1874-1883.
108. Rollema H, Shrikhande A, Ward KM, Tingley FD III, Coe JW, O'Neill BT, Tseng E, Wang EQ, Mather RJ, Hurst RS et al. 2010. Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence. Br J Pharmacol. 160:334-345.
109. Rollema H, Wilson GG, Lee TC, Folgering JH, Flik G. 2011. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex. Neurochem Int. 58:78-84.
110. Schroder H, Giacobini E, Struble RG, Zilles K, Maelicke A, Luiten PG, Strosberg AD. 1991. Cellular distribution and expression of cortical acetylcholine receptors in aging and Alzheimer's disease. Ann N Y Acade Sci. 640:189-192.
111. Semba J, Wakuta M. 2008. Chronic effect of nicotine on serotonin transporter mRNA in the raphe nucleus of rats: reversal by co-administration of bupropion. Psychiatry Clin Neurosci. 62:435-441.
112. Shim JC, Jung DU, Jung SS, Seo YS, Cho DM, Lee JH, Lee SW, Kong BG, Kang JW, Oh MK et al. 2012. Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial. Neuropsychopharmacology. 37:660-668.
113. Siebner HR, Dressnandt J, Auer C, Conrad B. 1998. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve. 21:1209-1212.
114. Stefan K, Kunesch E, Benecke R, Cohen LG, Classen J. 2002. Mechanisms of enhancement of human motor cortex excitability induced by interventional paired associative stimulation. J Physiol. 543:699-708.
115. Stefan K, Kunesch E, Cohen LG, Benecke R, Classen J. 2000. Induction of plasticity in the human motor cortex by paired associative stimulation. Brain. 123:572-584.
116. Stefan K, Wycislo M, Classen J. 2004. Modulation of associative human motor cortical plasticity by attention. J Neurophysiol. 92:66-72.
117. Tan H, Bishop SF, Lauzon NM, Sun N, Laviolette SR. 2009. Chronic nicotine exposure switches the functional role of mesolimbic dopa-mine transmission in the processing of nicotine's rewarding and aversive effects. Neuropharmacology. 56:741-751.
118. Tecchio F, Zappasodi F, Pasqualetti P, De Gennaro L, Pellicciari MC, Ercolani M, Squitti R, Rossini PM. 2008. Age dependence of primary motor cortex plasticity induced by paired associative stimulation. Clin Neurophysiol. 119:675-682.
119. Thirugnanasambandam N, Grundey J, Adam K, Drees A, Skwirba AC, Lang N, Paulus W, Nitsche MA. 2012. Nicotinergic impact on focal and non-focal neuroplasticity induced by non-invasive brain stimulation in non-smoking humans. Neuropsychopharmacology. 36:879-886.
120. Todd G, Kimber TE, Ridding MC, Semmler JG. 2010. Reduced motor cortex plasticity following inhibitory rTMS in older adults. Clin Neurophysiol. 121:441-447.
121. Umene-Nakano W, Yoshimura R, Yoshii C, Hoshuyama T, Hayashi K, Hori H, Katsuki A, Ikenouchi-Sugita A, Nakamura J. 2010. Varenicline does not increase serum BDNF levels in patients with nicotine dependence. Hum Psychopharmacol. 25:276-279.
122. Welsby P, Rowan M, Anwyl R. 2006. Nicotinic receptor-mediated enhancement of long-term potentiation involves activation of metabotropic glutamate receptors and ryanodine-sensitive calcium stores in the dentate gyrus. Eur J Neurosci. 24:3109-3118.
123. White HK, Levin ED. 1999. Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. Psychopharmacology (Berl). 143:158-165.
124. Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, McFalls E, Kovera C, McCarten JR. 1995. Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety. Pharmacol Biochem Behav. 51:509-514.
125. Wolters A, Sandbrink F, Schlottmann A, Kunesch E, Stefan K, Cohen LG, Benecke R, Classen J. 2003. A temporally asymmetric Hebbian rule governing plasticity in the human motor cortex. J Neurophysiol. 89:2339-2345.
126. Wonnacott S. 1990. The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci. 11:216-219.
127. Yamazaki Y, Jia Y, Hamaue N, Sumikawa K. 2005. Nicotine-induced switch in the nicotinic cholinergic mechanisms of facilitation of long-term potentiation induction. Eur J Neurosci. 22:845-860.
128. Yamazaki Y, Jia Y, Niu R, Sumikawa K. 2006. Nicotine exposure in vivo induces long-lasting enhancement of NMDA receptor-mediated currents in the hippocampus. Eur J Neurosci. 23:1819-1828.
129. Yamazaki Y, Jia Y, Wong JK, Sumikawa K. 2006. Chronic nicotine-induced switch in Src-family kinase signaling for longterm potentiation induction in hippocampal CA1 pyramidal cells. Eur J Neurosci. 24:3271-3284.
130. Zesiewicz TA, Greenstein PE, Sullivan KL, Wecker L, Miller A, Jahan I, Chen R, Perlman SL. 2012. A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. Neurology. 78:545-550.
131. Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W. 1996a. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol. 40:367-378.
132. Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W. 1996b. The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res. 109:127-135.